Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

6.3%

8 terminated/withdrawn out of 128 trials

Success Rate

90.5%

+4.0% vs industry average

Late-Stage Pipeline

26%

33 trials in Phase 3/4

Results Transparency

13%

10 of 76 completed trials have results

Key Signals

8 recruiting10 with results6 terminated

Enrollment Performance

Analytics

N/A

33(34.7%)

Phase 2

25(26.3%)

Phase 4

22(23.2%)

Phase 3

11(11.6%)

Phase 1

4(4.2%)

95Total

N/A(33)

Phase 2(25)

Phase 4(22)

Phase 3(11)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (128)

Showing 20 of 128 trials

NCT06622603Phase 4Recruiting

the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

Role: collaborator

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Role: collaborator

NCT02433795Phase 2Completed

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Role: collaborator

NCT07405931Not ApplicableRecruiting

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

Role: collaborator

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT07227428Phase 4Not Yet Recruiting

Comparison of Glucocorticoid Tapering Schedules in Rheumatoid Arthritis

Role: collaborator

NCT07147114Phase 4Not Yet Recruiting

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Role: lead

NCT07111585Not ApplicableRecruiting

Personalized Health Coaching for Patients With HF

Role: lead

NCT06889818Recruiting

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Role: collaborator

NCT04691674Not ApplicableCompleted

Optimal Placement Duration of Pancreatic Duct Stent

Role: collaborator

NCT06559202Completed

Inguinal and Axillary LN Size Distribution

Role: lead

NCT06138769Phase 2Active Not Recruiting

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Role: collaborator

NCT01917552Phase 3Recruiting

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Role: collaborator

NCT06104033Recruiting

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Role: collaborator

NCT04238780Not ApplicableUnknown

Erector Spinae Plane Block Reduces Postoperative Pain Following Laparoscopic Colorectal Operation

Role: lead

NCT05708157Unknown

Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis

Role: lead

NCT02268656Not ApplicableCompleted

Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction With a Single-dose Dexmedetomidine

Role: lead

NCT05406492Unknown

Population PK of Antibiotics, Sedative and Analgesics, and Antiplatelet Drugs During ECMO

Role: lead

NCT02439385Phase 2Completed

Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis

Role: lead

NCT03042520Unknown

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment

Role: collaborator